{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:36:41Z","timestamp":1792705001303,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.aohep.2020.03.001","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T03:13:53Z","timestamp":1584760433000},"page":"359-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity"],"prefix":"10.1016","volume":"19","author":[{"given":"Amedeo","family":"Lonardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Lugari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2020.03.001_bib0430","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"31","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.aohep.2020.03.001_bib0435","doi-asserted-by":"crossref","first-page":"k2734","DOI":"10.1136\/bmj.k2734","article-title":"Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults","volume":"362","author":"Byrne","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.aohep.2020.03.001_bib0440","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","article-title":"AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions","volume":"49","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0450","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/hepr.12656","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.aohep.2020.03.001_bib0455","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0460","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jhep.2016.06.010","article-title":"Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood","volume":"65","author":"Valenti","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0465","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.atherosclerosis.2017.01.008","article-title":"\u201cNot all forms of NAFLD were created equal\u201d Do metabolic syndrome-related NAFLD and PNPLA3-related NAFLD exert a variable impact on the risk of early carotid atherosclerosis?","volume":"257","author":"Lonardo","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0470","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease \u2013 meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.03.001_bib0475","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.gtc.2016.07.012","article-title":"Obesity epidemiology worldwide","volume":"45","author":"Arroyo-Johnson","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.aohep.2020.03.001_bib0480","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.aohep.2020.03.001_bib0485","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-8587(17)30292-9","article-title":"Metabolically healthy obesity: the low-hanging fruit in obesity treatment?","volume":"6","author":"Stefan","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0490","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1172\/JCI129186","article-title":"Metabolically healthy obesity: facts and fantasies","volume":"129","author":"Smith","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2020.03.001_bib0495","first-page":"179","article-title":"Significance of obesity in medical practice","volume":"90","author":"Vague","year":"1953","journal-title":"Mars Med"},{"key":"10.1016\/j.aohep.2020.03.001_bib0500","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/M14-2525","article-title":"Normal-weight central obesity: implications for total and cardiovascular mortality","volume":"163","author":"Sahakyan","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aohep.2020.03.001_bib0505","first-page":"408","article-title":"Lean, but not healthy: the \u2018metabolically obese, normal-weight\u2019 phenotype","volume":"19","author":"Ding","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.aohep.2020.03.001_bib0510","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.aohep.2020.03.001_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2017.08.003","article-title":"Introduction: the state of obesity in 2017","volume":"102","author":"Kushner","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.aohep.2020.03.001_bib0520","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","article-title":"Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index","volume":"21","author":"Pang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0525","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups","volume":"47","author":"Non-alcoholic Fatty Liver Disease Study Group","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0530","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.03.001_bib0535","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","article-title":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK","volume":"6","author":"Bhaskaran","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0540","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jhep.2009.10.010","article-title":"Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease","volume":"52","author":"Frith","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0545","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0550","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.ijo.0802519","article-title":"Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients","volume":"28","author":"Hsiao","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.aohep.2020.03.001_bib0555","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.2337\/diacare.27.11.2726","article-title":"Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects","volume":"27","author":"Thamer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2020.03.001_bib0560","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/0026-0495(92)90016-4","article-title":"The morphology and metabolism of intraabdominal adipose tissue in men","volume":"41","author":"M\u00e5rin","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.03.001_bib0565","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","article-title":"Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease","volume":"34","author":"Byrne","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0570","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17474124.2018.1415756","article-title":"Clinical relevance of liver histopathology and different histological classifications of NASH in adults","volume":"12","author":"Nascimbeni","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0575","article-title":"Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis","author":"Kim","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0580","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.02.013","article-title":"The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease","volume":"40","author":"Caldwell","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0585","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3748\/wjg.v23.i8.1458","article-title":"Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis","volume":"23","author":"Rinaldi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0590","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2020.03.001_bib0595","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0600","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0605","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.metabol.2018.11.009","article-title":"Metabolically healthy versus metabolically unhealthy obesity","volume":"92","author":"Iacobini","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.03.001_bib0610","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aohep.2020.03.001_bib0615","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.soard.2017.11.032","article-title":"Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?","volume":"14","author":"Haskins","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0620","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.numecd.2013.07.005","article-title":"Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis","volume":"24","author":"Sung","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0625","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2016.178","article-title":"Metabolically healthy obesity and the development of nonalcoholic fatty liver disease","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0630","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.metabol.2016.10.003","article-title":"Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status","volume":"66","author":"Huh","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.03.001_bib0635","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.diabet.2017.02.007","article-title":"Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease","volume":"43","author":"Guti\u00e9rrez-Grobe","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.aohep.2020.03.001_bib0640","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15015","article-title":"The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity","volume":"48","author":"Ampuero","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2020.03.001_bib0645","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/liv.14184","article-title":"Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease","volume":"39","author":"Kim","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.03.001_bib0650","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12020-017-1313-6","article-title":"Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals","volume":"57","author":"Hashimoto","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.aohep.2020.03.001_bib0655","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/oby.22536","article-title":"Association between nonalcoholic fatty liver disease and future deterioration of metabolic health: a cohort study","volume":"27","author":"Hwang","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.aohep.2020.03.001_bib0660","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ijo.2011.247","article-title":"Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men","volume":"36","author":"Chang","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.aohep.2020.03.001_bib0665","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2337\/dc14-0937","article-title":"Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy","volume":"37","author":"G\u00f3mez-Ambrosi","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2020.03.001_bib0670","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.aohep.2020.03.001_bib0675","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0680","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.aohep.2020.03.001_bib0685","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1210\/en.2016-1357","article-title":"Male 11\u03b2-HSD1 knockout mice fed trans-fats and fructose are not protected from metabolic syndrome or nonalcoholic fatty liver disease","volume":"157","author":"Larner","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.aohep.2020.03.001_bib0690","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/jc.2016-2498","article-title":"Genetic variation in the 11\u03b2-hydroxysteroid-dehydrogenase 1 gene determines NAFLD and visceral obesity","volume":"101","author":"Lutz","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.03.001_bib0695","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.metabol.2014.11.009","article-title":"The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy","volume":"64","author":"Liu","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.03.001_bib0700","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.aohep.2020.03.001_bib0705","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature17662","article-title":"An obligatory role for neurotensin in high-fat-diet-induced obesity","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.aohep.2020.03.001_bib0710","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/jc.2017-02751","article-title":"Increased plasma proneurotensin levels identify NAFLD in adults with and without type 2 diabetes","volume":"103","author":"Barchetta","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.03.001_bib0715","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ijo.2015.226","article-title":"Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity","volume":"40","author":"Mulder","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.aohep.2020.03.001_bib0720","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease","volume":"149","author":"du Plessis","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.03.001_bib0725","doi-asserted-by":"crossref","first-page":"e3120","DOI":"10.1097\/MD.0000000000003120","article-title":"Interactions of a PPARGC1A variant and a PNPLA3 variant affect nonalcoholic steatohepatitis in severely obese Taiwanese patients","volume":"95","author":"Tai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aohep.2020.03.001_bib0730","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2016.12.018","article-title":"Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage","volume":"257","author":"Di Costanzo","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0735","doi-asserted-by":"crossref","first-page":"E821","DOI":"10.1210\/jc.2014-4464","article-title":"Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant","volume":"100","author":"Mancina","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.aohep.2020.03.001_bib0740","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091314","article-title":"Dissociation of fatty liver and insulin resistance in I148M PNPLA3 carriers: differences in diacylglycerol (DAG) FA18:1 lipid species as a possible explanation","volume":"10","author":"Franko","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2020.03.001_bib0745","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.aohep.2020.03.001_bib0750","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2005.06.018","article-title":"Hepatic steatosis and insulin resistance: does etiology make a difference?","volume":"44","author":"Lonardo","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0755","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2010.03.039","article-title":"Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia","volume":"139","author":"Amaro","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.03.001_bib0760","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1210\/jc.2017-00056","article-title":"Fibronectin type iii domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"102","author":"Petta","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.03.001_bib0765","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajpath.2015.09.015","article-title":"Diet-induced obesity enhances progression of hepatocellular carcinoma through tenascin-C\/toll-like receptor 4 signaling","volume":"186","author":"Benbow","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0770","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","article-title":"CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity","volume":"67","author":"Fujiwara","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.03.001_bib0775","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","article-title":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","volume":"232","author":"Loria","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.aohep.2020.03.001_bib0780","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00592-018-1266-0","article-title":"A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?","volume":"56","author":"Lonardo","year":"2019","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0785","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2016-3440","article-title":"Association of NAFLD with diabetes and the impact of BMI changes: a 5-year cohort study based on 18,507 elderly","volume":"102","author":"Liu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.03.001_bib0790","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/jir.2009.0085","article-title":"Association between capacity of interferon-alpha production and metabolic parameters","volume":"30","author":"Tominaga","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.aohep.2020.03.001_bib0795","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2016-313155","article-title":"Adipose type I interferon signalling protects against metabolic dysfunction","volume":"67","author":"Wieser","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.03.001_bib0800","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2020.03.001_bib0805","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2015.03.032","article-title":"Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts","volume":"63","author":"Ma","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0810","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/gut.2008.151977","article-title":"High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.03.001_bib0815","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/apt.14803","article-title":"Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis","volume":"48","author":"Argo","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2020.03.001_bib0820","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2337\/db17-1539","article-title":"Increased hepatic PDGF-AA signaling mediates liver insulin resistance in obesity-associated type 2 diabetes","volume":"67","author":"Abderrahmani","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.aohep.2020.03.001_bib0825","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: evolving paradigms","volume":"23","author":"Lonardo","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.03.001_bib0830","doi-asserted-by":"crossref","first-page":"e6381","DOI":"10.1097\/MD.0000000000006381","article-title":"Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aohep.2020.03.001_bib0835","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.03.001_bib0840","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/oby.22627","article-title":"Ratio of conjugated chenodeoxycholic to muricholic acids is associated with severity of nonalcoholic steatohepatitis","volume":"27","author":"Chen","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.aohep.2020.03.001_bib0845","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1136\/gutjnl-2015-309456","article-title":"Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study","volume":"65","author":"Zarrinpar","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.03.001_bib0850","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/gutjnl-2016-312869","article-title":"miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression","volume":"67","author":"Hanin","year":"2018","journal-title":"Gut"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:40:55Z","timestamp":1761648055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268120300235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1665268120300235"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.03.001","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}